Literature DB >> 8798628

Mechanism-based inactivation of dopa decarboxylase by serotonin.

M Bertoldi1, P S Moore, B Maras, P Dominici, C B Voltattorni.   

Abstract

Pig kidney dopa decarboxylase (DDC) expressed in Escherichia coli is a homodimeric enzyme containing one catalytically active pyridoxal 5'-phosphate active site per subunit. In addition to catalyzing the decarboxylation of -aromatic amino acids, DDC also reacts with 5-hydroxytryptamine (5-HT), converting it to 5-hydroxyindolacetaldehyde and ammonia. These products have been identified by means of the enzymes alcohol dehydrogenase and glutamate dehydrogenase, together with high performance liquid chromatographic and mass spectroscopic analysis. The Kcat and Km values of this reaction were determined to be 0.48 min-1 and 0.47 mM, respectively. The NaBH4-reduced enzyme does not catalyze this reaction. Concurrent with this reaction, 5-HT inactivates DDC in both a time- and concentration-dependent manner and exhibits saturation of the rate of inactivation at high concentrations, with Ki and Kinact values of 0.40 mM and 0.023 min-1, respectively. Protection from inactivation by 5-HT was observed in the presence of the active site-directed inhibitor 3,4-dihydroxy-D-phenylalanine. Inactivation with [2-14C]5-HT results in the incorporation of 1 mol of label/enzyme subunit. Taken together, these findings indicate that 5-HT is both a substrate and a mechanism-based inactivator with a partition ratio for product formation versus inactivation of 21. The absorbance, CD, and fluorometric features of 5-HT-inactivated DDC have also been characterized. A speculative mechanism for the reaction and inactivation consistent with the experimental findings is presented.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8798628     DOI: 10.1074/jbc.271.39.23954

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Mutation of cysteine 111 in Dopa decarboxylase leads to active site perturbation.

Authors:  P Dominici; P S Moore; S Castellani; M Bertoldi; C B Voltattorni
Journal:  Protein Sci       Date:  1997-09       Impact factor: 6.725

2.  Dopa decarboxylase exhibits low pH half-transaminase and high pH oxidative deaminase activities toward serotonin (5-hydroxytryptamine).

Authors:  M Bertoldi; C B Voltattorni
Journal:  Protein Sci       Date:  2001-06       Impact factor: 6.725

Review 3.  A survey of oxidative paracatalytic reactions catalyzed by enzymes that generate carbanionic intermediates: implications for ROS production, cancer etiology, and neurodegenerative diseases.

Authors:  Victoria I Bunik; John V Schloss; John T Pinto; Natalia Dudareva; Arthur J L Cooper
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  2011

4.  Ornithine and glutamate decarboxylases catalyse an oxidative deamination of their alpha-methyl substrates.

Authors:  M Bertoldi; V Carbone; C Borri Voltattorni
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

5.  Molecular insights into the pathogenicity of variants associated with the aromatic amino acid decarboxylase deficiency.

Authors:  Riccardo Montioli; Barbara Cellini; Carla Borri Voltattorni
Journal:  J Inherit Metab Dis       Date:  2011-05-04       Impact factor: 4.982

6.  Reaction of dopa decarboxylase with L-aromatic amino acids under aerobic and anaerobic conditions.

Authors:  M Bertoldi; C Borri Voltattorni
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

7.  Facile in Vitro Biocatalytic Production of Diverse Tryptamines.

Authors:  Allwin D McDonald; Lydia J Perkins; Andrew R Buller
Journal:  Chembiochem       Date:  2019-06-05       Impact factor: 3.164

8.  Biochemical evaluation of the decarboxylation and decarboxylation-deamination activities of plant aromatic amino acid decarboxylases.

Authors:  Michael P Torrens-Spence; Pingyang Liu; Haizhen Ding; Kim Harich; Glenda Gillaspy; Jianyong Li
Journal:  J Biol Chem       Date:  2012-11-30       Impact factor: 5.157

Review 9.  Enzyme-catalyzed side reactions with molecular oxygen may contribute to cell signaling and neurodegenerative diseases.

Authors:  Victoria I Bunik; John V Schloss; John T Pinto; Gary E Gibson; Arthur J L Cooper
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

10.  Biochemical and computational approaches to improve the clinical treatment of dopa decarboxylase-related diseases: an overview.

Authors:  Barbara Cellini; Riccardo Montioli; Elisa Oppici; Carla Borri Voltattorni
Journal:  Open Biochem J       Date:  2012-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.